SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-186258
Filing Date
2024-07-26
Accepted
2024-07-26 16:29:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d868342d424b5.htm 424B5 3187
2 GRAPHIC g868342g00s01.jpg GRAPHIC 587683
  Complete submission text file 0001193125-24-186258.txt   809411
Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-265470 | Film No.: 241147331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)